Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours-Reference-Cited by-同舟云学术

Inhibiting PD-L1 palmitoylation enhances T-cell immune responses against tumours

Published:2019-03-25 Issue:4 Volume:3 Page:306-317
ISSN:2157-846X
Container-title:Nature Biomedical Engineering
language:en
Short-container-title:Nat Biomed Eng

Author:

Yao Han^ORCID,Lan Jiang,Li Chushu,Shi Hubing,Brosseau Jean-Philippe,Wang Huanbin,Lu Haojie,Fang Caiyun,Zhang Yao,Liang Lunxi,Zhou Xiaolin,Wang Chaojun,Xue Yu,Cui Yun,Xu Jie^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Computer Science Applications,Biomedical Engineering,Medicine (miscellaneous),Bioengineering,Biotechnology

Link

http://www.nature.com/articles/s41551-019-0375-6.pdf

Reference45 articles.

1. Brahmer, J. R. et al. Safety and activity of anti-PD-L1 antibody in patients with advanced cancer. N. Engl. J. Med. 366, 2455–2465 (2012).

2. Sonpavde, G. PD-1 and PD-L1 inhibitors as salvage therapy for urothelial carcinoma. N. Engl. J. Med. 376, 1073–1074 (2017).

3. Yao, H., Wang, H., Li, C., Fang, J. Y. & Xu, J. Cancer cell-intrinsic PD-1 and implications in combinatorial immunotherapy. Front. Immunol. 9, 1774 (2018).

4. Rodell, C. B. et al. TLR7/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy. Nat. Biomed. Eng. 2, 578–588 (2018).

5. Sharpe, A. H. & Pauken, K. E. The diverse functions of the PD1 inhibitory pathway. Nat. Rev. Immunol. 18, 153–167 (2018).

Cited by 319 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palmitoyltransferase ZDHHC3 is essential for the oncogenic activity of PML/RARα in acute promyelocytic leukemia;Acta Pharmacologica Sinica;2024-09-03

2. The role of novel protein acylations in cancer;European Journal of Pharmacology;2024-09

3. New horizons in the mechanisms and therapeutic strategies for PD-L1 protein degradation in cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-09

4. CoCl₂‐induced glioma hypoxia environment enhances CD47‐SIRPα to promote tumor immune evasion;MedComm – Oncology;2024-08-25

5. Exploring Protein S-Palmitoylation: Mechanisms, Detection, and Strategies for Inhibitor Discovery;ACS Chemical Biology;2024-08-19